Compare CAKE & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAKE | NVAX |
|---|---|---|
| Founded | 1972 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 1.6B |
| IPO Year | 1996 | 1996 |
| Metric | CAKE | NVAX |
|---|---|---|
| Price | $55.26 | $7.72 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 9 |
| Target Price | ★ $59.47 | $11.33 |
| AVG Volume (30 Days) | 1.1M | ★ 3.7M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.17% | N/A |
| EPS Growth | N/A | ★ 309.76 |
| EPS | ★ 3.06 | 2.58 |
| Revenue | ★ $3,751,806,000.00 | $1,123,479,000.00 |
| Revenue This Year | $6.16 | N/A |
| Revenue Next Year | $6.63 | N/A |
| P/E Ratio | $18.07 | ★ $3.10 |
| Revenue Growth | 4.75 | ★ 64.69 |
| 52 Week Low | $43.00 | $5.01 |
| 52 Week High | $69.70 | $11.85 |
| Indicator | CAKE | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 32.09 |
| Support Level | $52.59 | $6.35 |
| Resistance Level | $56.69 | $8.45 |
| Average True Range (ATR) | 2.08 | 0.54 |
| MACD | -0.22 | -0.28 |
| Stochastic Oscillator | 35.51 | 4.45 |
The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, Flower Child, and additional brands within its Fox Restaurant Concepts portfolio. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, Other FRC, and Other. The majority of the company's revenue comes from the Cheesecake Factory restaurants segment.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.